Efficacy of hyperbaric oxygen therapy as an adjunct therapy in the treatment of sleep disorders among patients with Parkinson's disease: a meta-analysis.

Objective: To systematically evaluate the efficacy of hyperbaric oxygen therapy (HBOT) as an adjunct therapy for treating sleep disorders in patients with Parkinson's disease (PD).

Methods: We conducted comprehensive searches in eight databases from inception through September 2023, including PubMed, Cochrane Library, Embase, Web of Science, SinoMed, China National Knowledge Infrastructure (CNKI), China Science and Technology Periodical Database (VIP), and Wanfang Database. The objective was to identify randomized controlled trials (RCTs) evaluating HBOT's effectiveness in alleviating sleep disorder symptoms in PD patients as an adjunct therapy.

A novel ratiometric fluorescent sensor for Ag+ based on two fluorophores.

A novel ratiometric fluorescent probe BCB was reported for the first time for the sensitive and selective analysis of Ag based on two Boradiazaindacene (BODIPY) as both the reference fluorophore and recognition part. Upon the addition of Ag ions, a strong fluorescence emission at 570 nm from recognition BODIPY would be appeared, whereas the fluorescence of the other BODIPY at 535 nm would be a constant reference fluorescence signal. As a result, the ratio of fluorescence intensity (λ570/λ535) was changed from 0.